By Milliam MurigiKenya’s animal feed manufacturers are urging the government to allow access to genetically modified (GM) ...

When Chinese drug developers need to see exactly how an experimental medicine binds to its target protein, or materials ...

In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.87% at $2.89. This change lagged the S&P 500's daily loss of 0.19%. At the same time, the Dow lost 0.59%, and the tech-heavy ...

Biogen has found a successor to longtime legal chief Susan Alexander, tapping former Vertex Pharmaceuticals executive and ...

Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...

The Charlottesville, Va. facility is designed to provide the state's ever-evolving biotechnology industry space to ...

The HudsonAlpha Institute for Biotechnology has been awarded an initial $15 million, with the potential for up to $160 ...

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

The Indian government has published a 10-year national bioeconomy roadmap sector, which includes a focus on alternative ...

Flashpoint Therapeutics, a biotechnology company pioneering the development of transformative nanomedicines, proudly congratulates its founder, Professor Chad A. Mirkin, on being named the recipient ...

Every year, the BIO International Convention brings together more than 20,000 leaders from across the global life sciences ...

Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company and a U.S.-based subsidiary of HLB, today announced that the first participant has been dosed in the Phase 1 clinical trial ...